DE69826795D1 - Staphylococcus aureus Therapie - Google Patents

Staphylococcus aureus Therapie

Info

Publication number
DE69826795D1
DE69826795D1 DE69826795T DE69826795T DE69826795D1 DE 69826795 D1 DE69826795 D1 DE 69826795D1 DE 69826795 T DE69826795 T DE 69826795T DE 69826795 T DE69826795 T DE 69826795T DE 69826795 D1 DE69826795 D1 DE 69826795D1
Authority
DE
Germany
Prior art keywords
staphylococcus aureus
therapy
strains
strain
directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69826795T
Other languages
English (en)
Other versions
DE69826795T2 (de
Inventor
Thalia Ioanna Nicas
David Albert Preston
Michael Lee Zeckel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69826795D1 publication Critical patent/DE69826795D1/de
Publication of DE69826795T2 publication Critical patent/DE69826795T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69826795T 1997-08-22 1998-08-18 Staphylococcus aureus Therapie Expired - Fee Related DE69826795T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22
US56712P 1997-08-22

Publications (2)

Publication Number Publication Date
DE69826795D1 true DE69826795D1 (de) 2004-11-11
DE69826795T2 DE69826795T2 (de) 2005-10-06

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69826795T Expired - Fee Related DE69826795T2 (de) 1997-08-22 1998-08-18 Staphylococcus aureus Therapie

Country Status (23)

Country Link
US (1) US5994297A (de)
EP (1) EP0897725B1 (de)
JP (1) JP2001513573A (de)
KR (1) KR100589548B1 (de)
CN (1) CN1276728A (de)
AT (1) ATE278413T1 (de)
AU (1) AU747418B2 (de)
BR (1) BR9811917A (de)
CA (1) CA2301589A1 (de)
CZ (1) CZ299098B6 (de)
DE (1) DE69826795T2 (de)
DK (1) DK0897725T3 (de)
EA (1) EA002602B1 (de)
ES (1) ES2229454T3 (de)
HU (1) HU226593B1 (de)
ID (1) ID24908A (de)
IL (2) IL134597A0 (de)
NO (1) NO327042B1 (de)
NZ (1) NZ502762A (de)
PT (1) PT897725E (de)
TR (1) TR200000475T2 (de)
UA (1) UA59410C2 (de)
WO (1) WO1999010006A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736860C (en) * 2008-08-30 2020-04-28 Targanta Therapeutics Corp. Methods of treatment using single doses of oritavancin
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
ATE278413T1 (de) 2004-10-15
EA002602B1 (ru) 2002-06-27
WO1999010006A1 (en) 1999-03-04
EP0897725A2 (de) 1999-02-24
DE69826795T2 (de) 2005-10-06
PT897725E (pt) 2004-12-31
AU8913798A (en) 1999-03-16
EP0897725B1 (de) 2004-10-06
NO20000851L (no) 2000-02-21
NO20000851D0 (no) 2000-02-21
IL134597A (en) 2007-09-20
BR9811917A (pt) 2000-08-15
ES2229454T3 (es) 2005-04-16
ID24908A (id) 2000-08-31
KR20010023108A (ko) 2001-03-26
CZ299098B6 (cs) 2008-04-23
EA200000250A1 (ru) 2000-08-28
NZ502762A (en) 2001-10-26
HUP0002920A3 (en) 2001-12-28
DK0897725T3 (da) 2004-12-13
KR100589548B1 (ko) 2006-06-15
CA2301589A1 (en) 1999-03-04
AU747418B2 (en) 2002-05-16
US5994297A (en) 1999-11-30
CZ2000619A3 (en) 2001-05-16
HUP0002920A2 (hu) 2001-01-29
HU226593B1 (en) 2009-04-28
NO327042B1 (no) 2009-04-06
JP2001513573A (ja) 2001-09-04
CN1276728A (zh) 2000-12-13
EP0897725A3 (de) 2000-02-09
IL134597A0 (en) 2001-04-30
TR200000475T2 (tr) 2000-08-21
UA59410C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
ES2155601T3 (es) Compuestos de benzolactama sustituidos como antagonistas de la sustancia p.
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
MX9305269A (es) Utilizacion del receptor de il-4 para la terapia,la profilaxis y el diagnostico de enfermedades alergicas, viricas, parasitarias y bacterianas asi como de infecciones por hongos.
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
PA8432701A1 (es) Derivados triciclicos sustituidos con fenilamino.
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
DE69634961D1 (de) Neue zyklische depsipeptid pf1022 derivate
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
FI924424A0 (fi) Hjaertskyddande tokoferolanaloger.
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
TNSN04035A1 (fr) Azithromycine en dose unique
ES2136457T3 (es) Dimeros unidos covalentemente de antibioticos glucopeptidicos.
EA200100700A1 (ru) Гены и белки и их применение
ATE278413T1 (de) Staphylococcus aureus therapie
EA200000407A1 (ru) Пептиды млекопитающих для лечения микробной инфекции
FR2674539B1 (fr) Procede de preparation enzymatique de macrolactone.
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
BR9106832A (pt) Herbicidas triazois biciclicos substituidos
ECSP951463A (es) Compuestos biciclicos
ATE204853T1 (de) Schädlingsbekämpfungsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee